コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 the CYP2E1 enzyme affinity for the substrate chlorzoxazone.
2 rat microsomes at varying concentrations of chlorzoxazone.
4 rm-selective substrates and inhibitors, only chlorzoxazone, a cytochrome P-450 2E1 (CYP2E1) substrate
5 of 4-AP was comparable, and not additive, to chlorzoxazone, an activator of Ca(2+)-dependent K(+) cha
6 ndicated by the increased production of 6-OH-chlorzoxazone and by glutathione depletion after incubat
7 al NOS oxygenase domains cocrystallized with chlorzoxazone and four nitroindazoles: 5-nitroindazole,
9 cs of a cytochrome P450 (CYP2E1) probe drug, chlorzoxazone, and to investigate the mechanism of these
10 ssessed using the oral clearance (CL(PO)) of chlorzoxazone (CHZ) in 20 NDN and 17 age, gender, and bo
11 d to measure the in vivo CYP3A activity, and chlorzoxazone (CHZ) oral clearance was used to assess in
14 ssessed by determination of the clearance of chlorzoxazone (CLZ), an in vivo CYP2E1-selective probe.
15 sing the probe drugs mephenytoin (CYP-2C19), chlorzoxazone (CYP-2E1), dapsone (multiple CYP enzymes),
17 was estimated by the fractional excretion of chlorzoxazone (fe(6-OH)) for 50 cases of BP and 50 contr
18 lot analysis, and rates of p-nitrophenol and chlorzoxazone hydroxylation were elevated 3- to 4-fold i
21 ncreased during postinjury recovery, whereas chlorzoxazone metabolism was suppressed to a lesser degr
22 The lowest energy docked configurations of chlorzoxazone, p-nitrophenol, and N-nitrosodimethylamine
30 systemic clearance of the CYP2E1 substrate, chlorzoxazone, when compared with normothermia after car
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。